George J N, Raskob G E
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Hosp Pract (1995). 1997 Sep 15;32(9):159-60, 163-6, 169-70, passim. doi: 10.1080/21548331.1997.11443569.
The appropriate management of ITP is still a matter of debate. The incidence and course of the disease are different in children and adults, and within these groups, new-borns and pregnant women have specific needs. Yet there is little unanimity regarding how and when to treat even the most severe cases. The problem is compounded by the difficulty of differentiating ITP from other causes of thrombocytopenia.
免疫性血小板减少症（ITP）的恰当管理仍是一个存在争议的问题。该疾病在儿童和成人中的发病率及病程有所不同，而且在这些群体中，新生儿和孕妇有特殊需求。然而，即便对于如何治疗以及何时治疗最严重的病例，也几乎没有一致意见。将ITP与其他血小板减少症病因区分开来存在困难，这使问题更加复杂。
